hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06292663, orgStudyIdInfo id: EMN-2023-08767, briefTitle: Can Preoperative Information Via Virtual Reality Affect Patient's Anxiety?, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-05, primaryCompletionDateStruct date: 2024-11, completionDateStruct date: 2024-11, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Zealand University Hospital, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to test and learn about Virtual Reality (VR) providing preoperative information to patients undergoing elective TKA surgery in spinal anesthesia. The main question(s) aim(s) to answer if:* Can preoperative information through a VR headset lower the patients preoperative anxiety?* Can VR information make the patients more ready for surgery. Painscore will also be collected.Participants will be randomized into two groups. One that will have preoperative information through VR versus standard information.If there is a comparison group: Researchers will compare enrolled TKA patients to see if VR have an impact on anxiety, readiness and pain, conditionsModule conditions: Anxiety, conditions: Surgery, conditions: Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: The subjects are being randomized to one of two groups., primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: The primary investigator will stay blinded in this study and an assistant to the investigator is screening and including the patients and collecting data., whoMasked: INVESTIGATOR, enrollmentInfo count: 88, type: ESTIMATED, armsInterventionsModule interventions name: Virtual Reality, outcomesModule primaryOutcomes measure: Preoperative anxiety, secondaryOutcomes measure: Cumulative sedative consumption, secondaryOutcomes measure: Opioid consumption, secondaryOutcomes measure: Patient preoperatively expectations, secondaryOutcomes measure: Patient preoperatively readiness, secondaryOutcomes measure: Adverse events, otherOutcomes measure: Level of pain, otherOutcomes measure: The need for information, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Zealand University Hospital, status: RECRUITING, city: Køge, state: Zealand, zip: 4600, country: Denmark, contacts name: Karsten Lomholt Lassen, CRNA, role: CONTACT, phone: 26131350, email: karlas@regionsjaelland.dk, contacts name: Nanna Wagner Christiansen, B.Eng, role: CONTACT, phone: 40306799, email: nanchr@regionsjaelland.dk, contacts name: Karsten Lomholt Lassen, Ph.D Student, CRNA, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 55.45802, lon: 12.18214, hasResults: False
protocolSection identificationModule nctId: NCT06292650, orgStudyIdInfo id: ZM-02, briefTitle: Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients, acronym: ZM-02, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-25, primaryCompletionDateStruct date: 2027-12-25, completionDateStruct date: 2028-12-25, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Zhongmou Therapeutics, class: INDUSTRY, descriptionModule briefSummary: This trial is meant to evaluate the safety and efficacy of ZM-02 in Retinitis pigmentosa (RP) patients. Unilateral intravitreal injections (IVT) will be given into the subject's Study Eye., conditionsModule conditions: Retinitis Pigmentosa, designModule studyType: INTERVENTIONAL, phases: EARLY_PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: ZM-02-L, interventions name: ZM-02-H, interventions name: ZM-02-S, outcomesModule primaryOutcomes measure: Incidence of adverse events and serious adverse events, primaryOutcomes measure: Changes in intraocular pressure (IOP) in Subjects, secondaryOutcomes measure: Change of FST outcome, secondaryOutcomes measure: Change of MLMT level, secondaryOutcomes measure: Change of Quality of Life, otherOutcomes measure: Change in best corrected visual acuity (BCVA), otherOutcomes measure: Change in visual field (VF), otherOutcomes measure: Change in Fundus Autofluorescence (FAF), otherOutcomes measure: Change in central foveal thickness (CFT) using Optical Coherence Tomography (OCT), otherOutcomes measure: Change in central macular thickness (CMT) using Optical Coherence Tomography (OCT), otherOutcomes measure: Changes in the fundus using fundus color photography, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beijing Tongren Hospital of Capital Medical University, city: Beijing, state: Beijing, country: China, contacts name: Pei Cao, role: CONTACT, phone: +86 18707134160, email: zmt@simbaeye.com, contacts name: Yin Shen, role: CONTACT, contacts name: Wenbin Wei, PhD, role: PRINCIPAL_INVESTIGATOR, contacts name: Laichun Lu, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06292624, orgStudyIdInfo id: HSEARS20230417002, briefTitle: Effectiveness of Intermittent Vacuum Therapy Combined With Aerobic Exercise in Individuals With Diabetes Mellitus, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-08-01, primaryCompletionDateStruct date: 2024-04-30, completionDateStruct date: 2024-04-30, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: The Hong Kong Polytechnic University, class: OTHER, collaborators name: Yan Chai Hospital Social Services, descriptionModule briefSummary: Consequences of the compromised vascular system in diabetes mellitus (DM) are among the most devastating complications. Reduction in blood flow and oxygen uptake of skeletal muscle leads to muscle fatigue and impaired skeletal muscle post-exercise adaptation. Recent studies showed that intermittent vacuum therapy (IVT) augments the blood flow of the foot in people with DM. This pilot study investigates the effects of combined IVT and aerobic exercise in improving lower limb muscle oxygenation and distal circulation in individuals with DM. Positive results of the study shed light on strategy that enhances the effectiveness of aerobic exercise in people with DM., conditionsModule conditions: Diabetes Mellitus, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Clinical trials with a single arm, receiving IVT combined with cycling exercise, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 12, type: ACTUAL, armsInterventionsModule interventions name: Intermittent vacuum therapy (Weyergans High Care® Medial, Germany), interventions name: Cycling exercise, outcomesModule primaryOutcomes measure: Muscle oxygenation, primaryOutcomes measure: Muscle oxygenation, secondaryOutcomes measure: Surface Electromyography, secondaryOutcomes measure: Surface Electromyography, secondaryOutcomes measure: Foot Sensation, secondaryOutcomes measure: Foot Sensation, secondaryOutcomes measure: Functional muscle strength, secondaryOutcomes measure: Functional muscle strength, secondaryOutcomes measure: Functional mobility, secondaryOutcomes measure: Functional mobility, eligibilityModule sex: ALL, minimumAge: 55 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The Hong Kong Polytechnic University, city: Hong Kong, country: Hong Kong, geoPoint lat: 22.27832, lon: 114.17469, hasResults: False
protocolSection identificationModule nctId: NCT06292611, orgStudyIdInfo id: ST-23-U35, briefTitle: Two Week Cumulative Extrinsic Stain Removal of a Battery-powered Toothbrush and a Manual Toothbrush, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-11-27, primaryCompletionDateStruct date: 2023-12-12, completionDateStruct date: 2024-01-25, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Church & Dwight Company, Inc., class: INDUSTRY, descriptionModule briefSummary: To evaluate and compare the extrinsic stain removal efficacy of a battery-powered toothbrush and a manual toothbrush following two weeks of brushing., conditionsModule conditions: Dental Devices, Home Care, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: INVESTIGATOR, enrollmentInfo count: 102, type: ACTUAL, armsInterventionsModule interventions name: Battery operated toothbrush, interventions name: Manual toothbrush, outcomesModule primaryOutcomes measure: Extrinsic Stain, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Salus Research, Inc., city: Fort Wayne, state: Indiana, zip: 46825, country: United States, geoPoint lat: 41.1306, lon: -85.12886, hasResults: False
protocolSection identificationModule nctId: NCT06292585, orgStudyIdInfo id: AEDH-MT, briefTitle: Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-08, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Changhai Hospital, class: OTHER, descriptionModule briefSummary: A prospective, multicenter, randomized controlled, open-label, blinded endpoint evaluation study., conditionsModule conditions: EpiDural Hematoma, conditions: Traumatic Brain Injury, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 168, type: ESTIMATED, armsInterventionsModule interventions name: MMA embolization plus medical therapy, interventions name: Medical therapy alone, outcomesModule primaryOutcomes measure: The proportion of patients who die within 72 hours after injury or progress to require craniotomy due to epidural hematoma., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Changhai hospital, city: Shanghai, state: Shanghai, zip: 200433, country: China, geoPoint lat: 31.22222, lon: 121.45806, hasResults: False
protocolSection identificationModule nctId: NCT06292572, orgStudyIdInfo id: 2024PI029, briefTitle: Clinical Characteristics and Surgical Outcomes of the Fellow Eye in Bilateral Retinal Detachments, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-11-01, completionDateStruct date: 2024-11-01, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Central Hospital, Nancy, France, class: OTHER, descriptionModule briefSummary: To assess the clinical features and the surgical outcomes of RD repair surgery of the fellow eye in bilateral retinal detachments, conditionsModule conditions: Retinal Detachment, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: Retinal Detachment Surgery, outcomesModule primaryOutcomes measure: Rate of surgical success, secondaryOutcomes measure: Visual Acuity, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: CHRU de Nancy, city: Vandoeuvre les nancy, state: Meurthe-et-Moselle, zip: 54511, country: France, geoPoint lat: 48.65, lon: 6.18333, hasResults: False
protocolSection identificationModule nctId: NCT06292559, orgStudyIdInfo id: STN or GPi in Meige Syndrom, briefTitle: A Comparison Between STN-DBS and GPi-DBS in Meige Syndrome Evaluated by Flexible Electrodes, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-30, primaryCompletionDateStruct date: 2024-11-30, completionDateStruct date: 2025-11-30, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Qilu Hospital of Shandong University, class: OTHER, descriptionModule briefSummary: Deep-brain stimulation (DBS) is an effective treatment for patients with Meige syndrome. The globus pallidus interna (GPi) and the subthalamic nucleus (STN) are both accepted targets for this treatment. Researchers designed this study to compare the 12-month outcomes for patients who undergo bilateral stimulation of the GPi or STN., conditionsModule conditions: Meige Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Bilateral STN deep brain stimulation, interventions name: Bilateral GPi deep brain stimulation, outcomesModule primaryOutcomes measure: Change in motor function, secondaryOutcomes measure: health-related quality of life, secondaryOutcomes measure: sleep quality status, secondaryOutcomes measure: Mental syndrome, secondaryOutcomes measure: Mental syndrome, eligibilityModule sex: ALL, minimumAge: 30 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Chao Zhang, status: RECRUITING, city: Jinan, state: Sichuan, zip: 250100, country: China, contacts name: chao zhang, role: CONTACT, phone: +8613969007232, email: chao_zhang@sdu.edu.cn, geoPoint lat: 36.66833, lon: 116.99722, hasResults: False
protocolSection identificationModule nctId: NCT06292546, orgStudyIdInfo id: ZYC-Hp2024, briefTitle: Effect of Intestinal Microecology After HDDT Combined With Probiotics for Helicobacter Pylori Eradication, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-09-01, completionDateStruct date: 2024-09-01, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Zhongshan Hospital (Xiamen), Fudan University, class: OTHER, descriptionModule briefSummary: The aim of this study was to evaluate the effect of Intestinal microecology after high dose dual therapy combined with probiotics for Helicobacter pylori eradication, conditionsModule conditions: H Pylori Infection Eradication, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Vonorason, interventions name: Amoxicillin, interventions name: Bacillus subtilis enteric-coated capsules, outcomesModule primaryOutcomes measure: Gut Microbiota, secondaryOutcomes measure: Fecal metabolites, secondaryOutcomes measure: Eradication rate, secondaryOutcomes measure: Frequency of the adverse events, secondaryOutcomes measure: Compliance rate of the drugs, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06292533, orgStudyIdInfo id: UTAR-30-2024, briefTitle: Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2024-10, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Universiti Tunku Abdul Rahman, class: OTHER, descriptionModule briefSummary: The goal of this study is to to evaluate the effectiveness of Ultrapulse for the treatment of androgenic alopecia among Malaysian. The main questions it aims to answer are:* the efficacy of Ultrapulse in treatment of androgenic alopecia among Malaysian* the safety and adverse effect of Ultrapulse treatment.* the quality of life of androgenic alopecia among Malaysian., conditionsModule conditions: Androgenic Alopecia, conditions: Alopecia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 92, type: ESTIMATED, armsInterventionsModule interventions name: Er:YAG laser, outcomesModule primaryOutcomes measure: Global assessment of hair growth, secondaryOutcomes measure: Patient satisfaction, secondaryOutcomes measure: Quality of Life of Patient, secondaryOutcomes measure: Adverse effects, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06292494, orgStudyIdInfo id: 1129052082, briefTitle: Focused Ultrasound for Drug-resistant Epilepsy, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2027-12-31, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Taipei Veterans General Hospital, Taiwan, class: OTHER_GOV, collaborators name: InSightec, descriptionModule briefSummary: Focused ultrasound (FUS) has been shown to differentially lesion or modulate (excite and inhibit) brain circuit and neural activity across a broad range of acoustic stimulus parameters (intensity, duty cycle, pulse repetition frequency and pulse duration) for decades. From our previous study, FUS sonication may suppress the number of epileptic signal bursts observed in EEG recordings after the induction of acute epilepsy. The presence of the suppressive effect was found in terms of the number of epileptic EEG spikes from the analysis of the unfiltered and theta-band EEG activity, and further discontinue the seizure attacks. EEG activity has also been consistently reported to have a positive correlation with the level of epilepsy, and FUS-mediated reduction of epileptic EEG activity was most notably observed, no matter lesioning or modulating effects. The aims of this study are to demonstrate the safety and efficacy of FUS technology in epilepsy patients and to estimate the optimal parameters of focused ultrasound exposure that will be used in the case of epilepsy., conditionsModule conditions: Focused Ultrasound, conditions: MR-guided FUS, conditions: Drug Refractory Epilepsy, conditions: Drug Resistant Epilepsy, conditions: Medication Resistant Epilepsy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Exablate 4000 Transcranial MRgfUS System, outcomesModule primaryOutcomes measure: pulse rate [Safety], primaryOutcomes measure: blood oxygen saturation level [Safety], primaryOutcomes measure: MRI [Safety], primaryOutcomes measure: Incidence of Treatment-Emergent Adverse Events [Tolerability], secondaryOutcomes measure: seizure frequency [efficacy], secondaryOutcomes measure: scalp EEG [efficacy], secondaryOutcomes measure: No. of seizure-free days [efficacy], eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Taipei Veterans General Hospital, status: RECRUITING, city: Taipei, country: Taiwan, contacts name: Cheng-Chia Lee, MD. PhD., role: CONTACT, email: cclee12@vghtpe.gov.tw, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False
protocolSection identificationModule nctId: NCT06292481, orgStudyIdInfo id: REC/RCR&AHS/23/0240, briefTitle: Combine Effects of Brunnstorm Movement Therapy and LLLT in Chronic Stroke Patient, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-08-01, primaryCompletionDateStruct date: 2023-09-30, completionDateStruct date: 2023-10-10, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: The primary objective of this study is to determine the combined effects of Brunnstorm movement therapy and low level laser therapy on upper limb function in chronic stroke patient., conditionsModule conditions: Chronic Stroke, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 48, type: ACTUAL, armsInterventionsModule interventions name: Brunnstorm movement therapy, interventions name: Combined Brunnstorm Movement therapy and low level laser therapy, outcomesModule primaryOutcomes measure: Fugle meyer Assessment test, primaryOutcomes measure: Box and block test, primaryOutcomes measure: Nine peg hole test, primaryOutcomes measure: to check Muscle tone, primaryOutcomes measure: to measure grip Strength, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Govt. Mian Munshi DHQ Teaching hospital, city: Lahore, state: Punjab, zip: 54000, country: Pakistan, geoPoint lat: 31.558, lon: 74.35071, hasResults: False
protocolSection identificationModule nctId: NCT06292468, orgStudyIdInfo id: REC/RCR&AHS/23/0238, briefTitle: Plantar Cutaneous Sensory Stimulation in Patients With Diabetic Neuropathy, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-07-07, primaryCompletionDateStruct date: 2023-08-18, completionDateStruct date: 2023-09-18, studyFirstPostDateStruct date: 2024-03-05, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: To determine the effects of plantar cutaneous sensory stimulation on foot tactile sensitivity, postural control, and spatiotemporal gait parameters in patients with diabetic neuropathy., conditionsModule conditions: Diabetic Neuropathies, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 50, type: ACTUAL, armsInterventionsModule interventions name: Traditional physical therapy, interventions name: Plantar cutaneous sensory stimulation, outcomesModule primaryOutcomes measure: Foot tactile sensitivity, primaryOutcomes measure: Postural control, primaryOutcomes measure: Spatiotemporal gait parameters, eligibilityModule sex: ALL, minimumAge: 45 Years, maximumAge: 67 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: PhysioFit, city: Faisalabad, state: Punjab, zip: 38000, country: Pakistan, geoPoint lat: 31.41554, lon: 73.08969, locations facility: Allied Hospital Faisalabad., city: Faisalābad, state: Punjab, zip: 38000, country: Pakistan, geoPoint lat: 31.41554, lon: 73.08969, hasResults: False